CMS CMS Primary Care First Model to Launch Early 2020 Thomas Sullivan Jul 26, 2019 1 Primary Care First is a set of voluntary five-year payment model options that reward value and quality by offering payment model…
Events 13th Annual Forum on Transparency and Aggregate Spend Thomas Sullivan Jul 26, 2019 0 The Thirteenth Annual Forum on Transparency and Aggregate Spend will take place August 12th through 14th, 2019, at the Ritz…
Drug Prices Mallinckrodt Sues CMS and HHS Over Rebates Thomas Sullivan Jul 25, 2019 0 Recently, a subsidiary of Mallinckrodt PLC, Mallinckrodt ARD LLC, filed a lawsuit against the United States Department of Health…
Uncategorized Bipartisan Bill Likely to Be Drafted and Introduced to Lower Prescription… Thomas Sullivan Jul 24, 2019 0 The bipartisan duo of Senator Chuck Grassley (R-IA) and Ron Wyden (D-OR) – the Chairman and Ranking Member of the Senate Finance…
Conflict of Interest GSK Modifies Ethics-Based Representative Compensation Thomas Sullivan Jul 23, 2019 0 GlaxoSmithKline (GSK) has been known to have some of the strictest pay rules in the pharmaceutical industry, due at least in part…
CMS CMS Seeks Patient Input Over Paperwork Initiative Thomas Sullivan Jul 22, 2019 0 The United States Centers for Medicare and Medicaid Services (CMS) issued a Request for Information (RFI) seeking new ideas on how…
Uncategorized Trump Signs Executive Order Focused on Health Care Transparency Thomas Sullivan Jul 19, 2019 0 President Donald Trump signed an Executive Order focused on increasing transparency around the cost and quality of health care.…
CMS Three Pharma Companies Sue HHS, Judge Rules in Their Favor Thomas Sullivan Jul 18, 2019 0 In June 2019, several drug manufacturers filed a lawsuit against the United States Department of Health and Human Services (HHS)…
Uncategorized SCOTUS Rules Judge Should Decide Merck Labeling Case Thomas Sullivan Jul 17, 2019 0 Right before their term ended, the Supreme Court of the United States issued a ruling in Merck Sharp & Dohme Corp. v. Albrecht…
FDA New FDA Draft Guidance on Opioid Benefit-Risk Assessment Includes… Thomas Sullivan Jul 16, 2019 0 Recently, the US Food and Drug Administration (“FDA”) published a new draft guidance entitled Opioid Analgesic Drugs:…